Clinical Trial Update: Switching From PI to RALtegravir in HIV Stable Patients [Phase 3]

View source ↗

Summary

Phase 3 trial updated results on switching from protease inhibitors to raltegravir in HIV-infected patients stable on therapy; study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: HIV Infections | Phase 3 | Status: COMPLETED